Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Nasini

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1992
Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine releaseS Carozzi, M G Nasini, P M Caviglia, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1994
Peritoneal dialysis solution pH and Ca2+ concentration regulate peritoneal macrophage and mesothelial cell activationS Carozzi, P M Caviglia, M G Nasini, et al.
Journal of Clinical Microbiology|August 1, 1989
Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysisS Carozzi, M Salit, A Cantaluppi, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1990
Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1989
Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitisS Carozzi, M G Nasini, C Schelotto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Treatment of anaemia in CAPD patients with recombinant human erythropoietinA Ramello, U Malcangi, M Bruno, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 5, 2005
[Two-chamber hemodiafiltration: comparison between exogenous reinfusion (PFD) and endogenous reinfusion (HFR)]C Schelotto, O Santoni, M G Nasini, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1992
Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1992
Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine releaseS Carozzi, M G Nasini, P M Caviglia, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1994
Peritoneal dialysis solution pH and Ca2+ concentration regulate peritoneal macrophage and mesothelial cell activationS Carozzi, P M Caviglia, M G Nasini, et al.
Journal of Clinical Microbiology|August 1, 1989
Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysisS Carozzi, M Salit, A Cantaluppi, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Peritoneal dialysis fluid (PDF) C++ and 1,25(OH)2D3 modulate peritoneal macrophage (PM0) antimicrobial activity in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1990
Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
ASAIO Transactions|July 1, 1989
Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitisS Carozzi, M G Nasini, C Schelotto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Treatment of anaemia in CAPD patients with recombinant human erythropoietinA Ramello, U Malcangi, M Bruno, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1990
Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patientsS Carozzi, M G Nasini, C Schelotto, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 5, 2005
[Two-chamber hemodiafiltration: comparison between exogenous reinfusion (PFD) and endogenous reinfusion (HFR)]C Schelotto, O Santoni, M G Nasini, et al.
Pageof 3